Ajanta Pharma Limited (NSE:AJANTPHARM) — Market Cap & Net Worth

$3.81 Billion USD · Rs352.66 Billion INR · Rank #4269

Market Cap & Net Worth: Ajanta Pharma Limited (AJANTPHARM)

Ajanta Pharma Limited (NSE:AJANTPHARM) has a market capitalization of $3.81 Billion (Rs352.66 Billion) as of May 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #4269 globally and #180 in its home market, demonstrating a 1.57% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ajanta Pharma Limited's stock price Rs2822.70 by its total outstanding shares 124935624 (124.94 Million). Analyse Ajanta Pharma Limited cash conversion from operations to see how efficiently the company converts income to cash.

Ajanta Pharma Limited Market Cap History: 2015 to 2026

Ajanta Pharma Limited's market capitalization history from 2015 to 2026. Data shows growth from $1.11 Billion to $3.81 Billion (10.71% CAGR).

Index Memberships

Ajanta Pharma Limited is a constituent of 5 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY PHARMA CNXPHARMA	$86.64 Billion	4.40%	#9 of 20
NIFTY 500 NIFTY500	$3.11 Trillion	0.12%	#166 of 500
NIFTY MIDCAP 150 NIFTYMIDCAP150	$695.80 Billion	0.55%	#80 of 150
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.11 Trillion	0.34%	#92 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.20 Trillion	0.12%	#164 of 750

Weight: Ajanta Pharma Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Ajanta Pharma Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Ajanta Pharma Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.08x

Ajanta Pharma Limited's market cap is 0.08 times its annual revenue

Industry average: 1.04x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.41x

Ajanta Pharma Limited's market cap is 0.41 times its annual earnings

Industry average: 8.30x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$1.50 Billion	$17.08 Billion	$4.01 Billion	0.09x	0.37x
2017	$1.26 Billion	$19.16 Billion	$5.07 Billion	0.07x	0.25x
2018	$1.01 Billion	$20.60 Billion	$4.69 Billion	0.05x	0.21x
2019	$838.73 Million	$20.16 Billion	$3.87 Billion	0.04x	0.22x
2020	$1.41 Billion	$25.62 Billion	$4.68 Billion	0.06x	0.30x
2021	$1.94 Billion	$28.47 Billion	$6.54 Billion	0.07x	0.30x
2022	$1.59 Billion	$32.84 Billion	$7.13 Billion	0.05x	0.22x
2023	$2.76 Billion	$37.43 Billion	$5.88 Billion	0.07x	0.47x
2024	$3.96 Billion	$42.09 Billion	$8.16 Billion	0.09x	0.49x
2025	$3.74 Billion	$46.48 Billion	$9.20 Billion	0.08x	0.41x

Competitor Companies of AJANTPHARM by Market Capitalization

Companies near Ajanta Pharma Limited in the global market cap rankings as of May 4, 2026.

Key companies related to Ajanta Pharma Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#499	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#525	Zoetis Inc	NYSE:ZTS	$50.31 Billion	$114.16
#526	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$50.29 Billion	CN¥53.88
#572	GALDERMA GROUP AG	NYSE:GALDY	$45.88 Billion	$42.15

Ajanta Pharma Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Ajanta Pharma Limited's market cap moved from $1.11 Billion to $ 3.81 Billion, with a yearly change of 10.71%.

Year	Market Cap	Change (%)
2026	Rs3.81 Billion	+1.94%
2025	Rs3.74 Billion	-5.57%
2024	Rs3.96 Billion	+43.66%
2023	Rs2.76 Billion	+73.44%
2022	Rs1.59 Billion	-18.22%
2021	Rs1.94 Billion	+37.48%
2020	Rs1.41 Billion	+68.63%
2019	Rs838.73 Million	-16.70%
2018	Rs1.01 Billion	-19.83%
2017	Rs1.26 Billion	-16.02%
2016	Rs1.50 Billion	+35.08%
2015	Rs1.11 Billion	--

End of Day Market Cap According to Different Sources

On May 4th, 2026 the market cap of Ajanta Pharma Limited was reported to be:

Source	Market Cap
Yahoo Finance	$3.81 Billion USD
MoneyControl	$3.81 Billion USD
MarketWatch	$3.81 Billion USD
marketcap.company	$3.81 Billion USD
Reuters	$3.81 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Ajanta Pharma Limited

NSE:AJANTPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$3.81 Billion

Rs352.66 Billion INR

Market Cap Rank

#4269 Global

#180 in India

Share Price

Rs2822.70

Change (1 day)

+0.66%

52-Week Range

Rs2388.40 - Rs3119.50

All Time High

Rs3395.67